Penumbra (PEN): Utang-utang marang kapitalisasi buku

Logo grafis Penumbra (PEN)

Penumbra, Inc. (PEN) creates a critical environment for saving lives during thrombosis by deeply integrating its systems into surgical protocols. Dominance in vascular medicine is driven by the implementation of innovative AI catheters. Production stability is maintained through strict control of material supply chains. On GURU.Markets, the leverage-to-market capitalization ratio clearly demonstrates the capital structure, where the 0.13 indicator expresses the state of the metric.

Rasio utang-utang marang kapitalisasi buku Penumbra Medical (PEN): kanggo periode 04.07.2022 - 28.10.2026
Sampel barang Penumbra Medical

For Penumbra, Inc. (PEN), this indicator measures the proportion of debt obligations within the equity structure, allowing for an assessment of the business's financial autonomy while developing costly thrombus aspiration systems. Analyzing the ratio of borrowed funds to capitalization helps balance default risk against leverage efficiency, confirming that the high margins of medical devices ensure the company's stability.

Pesaing Penumbra, Inc.

Rasio utang marang kapitalisasi buku DexCom, Inc.|Rasio utang marang aset resik novanta.com NOVT|Haemonetics - Utang-utang marang kapitalisasi buku|INSP: Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku PROCEPT BioRobotics Inc (PRCT)|CONMED Inc. (CNMD) - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku PLSE (Pulse Biosciences, Inc.)|Utang-utang marang nilai buku inmodemd.com (INMD)|Utang marang nilai buku PMI|Utang-utang marang kapitalisasi buku Surmodics Inc SRDX|Utang marang nilai buku senseonics.com (SENS)|Utang marang modal buku NeuroPace Medical NPCE|Utang-utang marang kapitalisasi buku TCMD (Tactile Systems Technology Inc.)|SNWV - Utang-utang marang aset resik|OM (Outset Medical) - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Electromed|LNSR - Utang marang nilai buku|Rasio utang marang aset resik RCEL|Rasio utang marang kapitalisasi buku PROF (Profound Medical Corp.)|Utang marang nilai buku bairdmed.com (BDMD)|EDAP: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Apyx Medical Corp APYX|IceCure Medical, Ltd. (ICCM) - Utang-utang marang kapitalisasi buku|LUNG - Rasio utang marang nilai buku|telabio.com - Utang-utang marang kapitalisasi buku|CytoSorbents Corporation (CTSO) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku SRTS|Utang marang nilai buku Zynex Medical|Utang-utang marang kapitalisasi buku ECOR|Utang-utang marang kapitalisasi buku RBOT (vicarioussurgical.com)|Rasio utang marang kapitalisasi buku Inspira Technologies IINN|ICU - Rasio utang marang kapitalisasi buku|Utang marang nilai buku IRIDEX Corp. (IRIX)|INBS - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku XAIR|PFSA (Profusa, Inc) - Utang-utang marang nilai buku|STRATA Skin Sciences Inc. - Rasio utang marang kapitalisasi buku|Utang marang aset resik glucotrack.com (GCTK)|Utang marang nilai buku NAOV|Utang-utang marang kapitalisasi buku Venus Concept Inc (VERO)|Utang-utang marang kapitalisasi buku NUWE|Aethlon Medical Corp - Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku TransEnterix|AVGR: Rasio utang-utang marang kapitalisasi buku|BSGM (Biosig Technologies) - Rasio utang marang kapitalisasi buku|Cutera Inc. (CUTR) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku KNW (Know Labs Corp)|Utang-utang marang nilai buku NARI|Rasio utang marang kapitalisasi buku Nevro Corp. NVRO|Rasio utang marang nilai buku reshapelifesciences.com RSLS|Utang marang nilai buku Silk Road Medical (SILK)